Robotic-assisted laparoscopic radical prostatectomy: Initial outcomes of 500 cases

We aimed to present our experience of robot-assisted laparoscopic radical prostatectomy (RARP).

The study was a retrospective review of 500 patients who underwent RARP between March 2015 and July 2021 in our clinic. A transperitoneal approach was used in all patients. All patients had clinically organ-confined prostate cancer (≤ cT2c).

The mean age of the patients was 64.6 ± 5.7 years. The median PSA was 11.4 ng/dL (range 0.3-92.7). The mean operative time was 183.5 min. Positive surgical margin rate was 19.4%. During a mean follow-up of 23.5 months, 96 patients (19.2%) received adjuvant radiotherapy due to the biochemical recurrence and 28 patients (16%) with lymph node positivity received early adjuvant hormone therapy. Considering the continence rates, 69% of the patients were total continence in the 3^rd month, while this rate increased to 83 in the 6^th month and 91% in the 12^th month.

RARP is a safe and feasible method for experienced centers with patient comfort, surgeon comfort, and successful oncological and functional results.